PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,273,656 | +53.1% | 400,054 | +100.0% | 0.03% | -15.6% |
| Q2 2023 | $8,015,082 | -1.8% | 200,027 | 0.0% | 0.03% | -5.9% |
| Q1 2023 | $8,163,102 | +5.7% | 200,027 | 0.0% | 0.03% | -2.9% |
| Q4 2022 | $7,723,042 | -46.2% | 200,027 | -25.9% | 0.04% | -52.7% |
| Q3 2022 | $14,363,000 | -8.8% | 270,027 | 0.0% | 0.07% | -3.9% |
| Q2 2022 | $15,743,000 | -27.6% | 270,027 | -5.3% | 0.08% | -14.4% |
| Q1 2022 | $21,753,000 | +39.6% | 285,027 | +10.1% | 0.09% | +57.9% |
| Q4 2021 | $15,580,000 | +39.1% | 258,936 | +29.5% | 0.06% | +23.9% |
| Q3 2021 | $11,202,000 | +8.6% | 200,027 | +17.6% | 0.05% | +2.2% |
| Q2 2021 | $10,317,000 | +17.8% | 170,027 | +36.0% | 0.04% | 0.0% |
| Q1 2021 | $8,761,000 | – | 125,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |